Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)

NCT00819910 is registered in ClinicalTrials.gov with Ahmad Slim as lead sponsor.

NCT NCT00819910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00819910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL)
Lead sponsor
Ahmad Slim
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2008
Completion date
May 31, 2010
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia in type 4 hyperlipidemia, non diabetic subjects with normoglycemia